The head of the European Medicines Agency's vaccines strategy, Marco Cavaleri, confirmed a clear link between the AstraZeneca vaccine and a rare blood clot in the brain.
However, Cavaleri said the cause of the issue was still unknown and gave no indication that the regulatory body would change its recommendation regarding this particular vaccine.
The director of the Croatian Institute of Public Health, Krunoslav Capak, said Croatia would wait for further assessment from the European Medicines Agency before making a ruling on the vaccine.
"It's very unlikely that they will call for the suspension of the AstraZeneca vaccine. It is possible, however, that they will alter their recommendations with regards to age groups, but I doubt the vaccine will be suspended altogether," said Capak.
Several EU countries, including the Netherlands, Sweden, and Finland, have already restricted its use to older people; while Denmark suspended the AstraZeneca vaccine altogether.
The EMA continues to maintain that the benefits of the jab outweigh any risks.
- Croatia and 12 other EU members reach agreement on Covid passport
- 12,096 active coronavirus cases in Croatia
- 3,099 new cases of coronavirus in Croatia
- Grlić Radman: The EU is not looking to split-up BiH
- Croatia's coronavirus test positivity rate continues to decline
- Rimac and Sveta Nedelja sign contract: "We have big plans"